A Translational Tool to Facilitate Use of Apolipoprotein B for Clinical Decision-Making.
Justine ColeJames Dorian OtvosAlan Thomas RemaleyPublished in: Clinical chemistry (2022)
Providing visibility to discrepancies among LDL-C, non-HDL-C, and apoB should help to facilitate more rapid and widespread adoption of apoB for managing ASCVD risk.
Keyphrases